Vaughn M Kailian's Net Worth

$1.28 Million

Estimate Recalculated Nov 8, 2024 04:38PM EST

Who is Vaughn M Kailian?

Vaughn M Kailian has an estimated net worth of $1.28 Million. This is based on reported shares across multiple companies, which include PEPLIN INC, TriVascular Technologies, Inc., Radius Health, Inc., Verastem, Inc., Syndax Pharmaceuticals Inc, Pacira Pharmaceuticals, Inc., ARATANA THERAPEUTICS, INC., Conatus Pharmaceuticals Inc, Epizyme, Inc., Cerecor Inc., CEPHALON INC, CHIASMA, INC, VIACELL INC, MEMORY PHARMACEUTICALS CORP, and MILLENNIUM PHARMACEUTICALS INC.

SEC CIK

Vaughn M Kailian's CIK is 0001180429

Past Insider Trading and Trends

2004 was Vaughn M Kailian's most active year for acquiring shares with 3 total transactions. Vaughn M Kailian's most active month to acquire stocks was the month of April. 2011 was Vaughn M Kailian's most active year for disposing of shares, totalling 7 transactions. Vaughn M Kailian's most active month to dispose stocks was the month of September. 2003 saw Vaughn M Kailian paying a total of $476,273.52 for 152,988 shares, this is the most they've acquired in one year. In 2004 Vaughn M Kailian cashed out on 105,130 shares for a total of $1,757,500.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PEPLIN INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.42M
—
—
0
Nov 11
Form 4
+0.07%
2.25K
$8.11
$18,233.80
3.42M
Feb 11 - Feb 12
Form 4
+0.03%
1K
$8.00
$7,992.00
3.42M
Feb 9
Form 4
+0.08%
2.65K
$7.80
$20,654.40
3.42M
Feb 5
Form 4
+0.23%
7.71K
$8.04
$61,948.00
3.41M
Jan 23 - Jan 27
Form 4
+0.10%
3.52K
$8.07
$28,369.80
3.41M
Jan 21 - Jan 22
Form 4
+0.29%
9.88K
$8.14
$80,402.20
3.4M
Jan 15 - Jan 20
Form 4
+0.20%
6.91K
$7.03
$48,584.33
3.39M
Jan 13
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

TriVascular Technologies, Inc. No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.78M
—
—
1.78M
Apr 22
Form 3
—
0
—
—
0
No matching records found

Syndax Pharmaceuticals Inc (SNDX) Snapshot price: $19.1

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.17M
—
—
2.17M
Mar 8
Form 3
—
0
—
—
0
No matching records found

Pacira Pharmaceuticals, Inc. (PCRX) Snapshot price: $13.89

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-15.20%
-500.00K
$27.86
-$13,930,000.00
2.79M
Mar 11
Form 4
+16.31%
461.54K
$6.50
$2,999,997.00
3.29M
Nov 21
Form 4/A
+2,942.53%
2.74M
$7.00
—
2.83M
Feb 8
Form 4
+2,942.53%
2.74M
$7.00
—
2.83M
Feb 8
Form 3
—
0
—
—
0
No matching records found

ARATANA THERAPEUTICS, INC. No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-17.90%
-600.00K
$20.02
-$12,012,000.00
2.75M
Mar 10
Form 4
-19.93%
-872.70K
—
—
3.51M
Mar 3
Form 4
+944.84%
3.93M
$6.00
—
4.35M
Jul 2
Form 3
—
0
—
—
0
No matching records found